Literature DB >> 1748474

The role of interferon alpha/beta in the induction of intestinal pathology in mice.

P Garside1, M V Felstein, E A Green, A M Mowat.   

Abstract

We have investigated the role of interferon-alpha/beta (IFN-alpha/beta) and IFN-dependent effector cells in causing enteropathy in mice. The IFN-inducer polyinosinic:polycytydylic acid (poly I:C) augmented the natural killer (NK) cell activation normally seen in neonatal (CBA x BALB/c)F1 mice with graft-versus-host reaction (GVHR) and exacerbated the systemic and intestinal consequences of GVHR. Poly I:C itself produced a similar pattern of intestinal pathology when administered to normal mice. The effects of poly I:C on NK cell activity and intestinal architecture in normal mice could be reproduced by a single injection of purified IFN-alpha/beta and the intestinal lesions caused by IFN-alpha/beta were prevented by in vivo depletion of NK cells with anti-asialo GM1. These results indicate that IFN-alpha/beta may play an important role in immunologically mediated enteropathies by virtue of its ability to activate NK cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748474      PMCID: PMC1384605     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  The effects of polyinosinic:polycytidylic acid on the graft-versus-host reaction. III: Increased severity of the reaction with delayed pI:C treatment.

Authors:  A Peres; S Amlani; M Kornbluth; T A Seemayer; W S Lapp
Journal:  Transplantation       Date:  1989-07       Impact factor: 4.939

Review 2.  Graft-vs.-host reactions: mechanisms and contemporary theories.

Authors:  H Bril; R Benner
Journal:  Crit Rev Clin Lab Sci       Date:  1985       Impact factor: 6.250

3.  Enhanced interferon-alpha/beta (IFN-alpha/beta) and defective IFN-gamma production in chronic graft versus host disease: a potential mechanism for immunosuppression.

Authors:  M G Cleveland; R G Lane; G R Klimpel
Journal:  Cell Immunol       Date:  1987-11       Impact factor: 4.868

4.  Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction.

Authors:  A M Mowat
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

5.  Augmentation of mouse natural killer cell activity by interferon and interferon inducers.

Authors:  J Y Djeu; J A Heinbaugh; H T Holden; R B Herberman
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

6.  The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.

Authors:  A Peres; F P Nestel; T A Seemayer; W S Lapp
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

7.  In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease.

Authors:  M G Cleveland; C R Annable; G R Klimpel
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

8.  Experimental studies of immunologically mediated enteropathy: IV. Correlation between immune effector mechanisms and type of enteropathy during a GvHR in neonatal mice of different ages.

Authors:  M V Felstein; A M Mowat
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

9.  Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.

Authors:  P F Piguet; G E Grau; B Allet; P Vassalli
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.

Authors:  G Degliantoni; M Murphy; M Kobayashi; M K Francis; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more
  5 in total

1.  Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease.

Authors:  S Daum; U Bauer; H D Foss; D Schuppan; H Stein; E O Riecken; R Ullrich
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

2.  Natural killer cells and tumour necrosis factor-alpha-mediated enteropathy in mice.

Authors:  P Garside; A M Mowat
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

3.  A role for IL-4 in immunologically mediated enteropathy.

Authors:  A M Mowat; M B Widmer
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

4.  Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistance.

Authors:  Mahima Swamy; Lucie Abeler-Dörner; James Chettle; Tanel Mahlakõiv; Delphine Goubau; Probir Chakravarty; George Ramsay; Caetano Reis e Sousa; Peter Staeheli; Barbara A Blacklaws; Jonathan L Heeney; Adrian C Hayday
Journal:  Nat Commun       Date:  2015-05-19       Impact factor: 14.919

5.  Intraluminal administration of poly I:C causes an enteropathy that is exacerbated by administration of oral dietary antigen.

Authors:  Romina E Araya; Jennifer Jury; Constanza Bondar; Elena F Verdu; Fernando G Chirdo
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.